Friday, Sep 25, 2020 | Last Update : 05:25 AM IST

185th Day Of Lockdown

Maharashtra128396397321434345 Andhra Pradesh6543855794745558 Tamil Nadu5636915082109076 Karnataka5485574446588331 Uttar Pradesh3742773076115366 Delhi2606232243755123 West Bengal2378692080424606 Odisha196888161044805 Telangana1792461481391070 Bihar174266159700878 Assam165582135141608 Kerala15445898720614 Gujarat1289491093113382 Rajasthan1227201023301352 Haryana118554984101177 Madhya Pradesh115361814752007 Punjab105220814752860 Chhatisgarh9562358833680 Jharkhand7643862945626 Jammu and Kashmir68614480791024 Uttarakhand4440432154501 Goa3055224347360 Puducherry2489519311467 Tripura2378616955245 Himachal Pradesh133869232125 Chandigarh109688342123 Manipur9537736959 Arunachal Pradesh8416607113 Nagaland5730459810 Meghalaya4733252838 Sikkim2447190529 Mizoram158510120
  India   All India  17 Jun 2020  Dexamethasone could be the miracle drug to reduce COVID-19 mortality rate

Dexamethasone could be the miracle drug to reduce COVID-19 mortality rate

THE ASIAN AGE | VINEETA PANDEY
Published : Jun 17, 2020, 2:25 am IST
Updated : Jun 17, 2020, 2:25 am IST

Earlier, several other measures such as convalescent plasma therapy were tried to save lives but none have been found to be as effective.

Representational image.
 Representational image.

New Delhi: For countries battling high mortality rate due to the coronavirus pandemic, steroid Dexamethasone can be a boon, as researchers in England have claimed that it can reduce COVID-19 deaths by one-third in severely ill hospitalised patients. This is the first evidence that a drug can improve the survival rate. Earlier, several other measures such as convalescent plasma therapy were tried to save lives but none have been found to be as effective.

The chief investigators of the randomised evaluation of COVID -19 therapy (recovery) trial said low-cost Dexamethasone reduces death by up to one-third in hospitalised patients with severe respiratory complications. Dexamethasone reduces inflammation and lowers the body's immune response and is used with other drugs to treat different types of cancer:

 

“Dexamethasone is the first drug to be shown to improve survival in COVID-19. This is an extremely welcome result. The survival benefit is clear and large in those patients who are sick enough to require oxygen treatment, so Dexamethasone should now become standard of care in these patients. Dexamethasone is inexpensive, on the shelf, and can be used immediately to save lives worldwide,” said Peter Horby, professor of emerging infectious diseases in the Nuffield Department of Medicine, University of Oxford, and one of the Chief Investigators for the trial.

Dr Ashish K Jha, director of Harvard Global Health Institute, said: “One feature of COVID is that while some folks have mild disease, others get very, very sick. We think the immune response is a major component of why some folks get so sick. Dexamethasone is a steroid that blocks/mediates the immune response. It’s cheap and widely available.”

 

Till Tuesday morning, India had reported 3,43,091 cases and 9,900 deaths, out of which 10,667 were fresh cases, and 380 new deaths. In the last 24 hours, 10,215 COVID-19 patients were discharged while the total number of cured stands at 1,80,012 patients.

According to health ministry the recovery rate is now 52.47 per cent . Currently, 1,53,178 active cases are under medical supervision. However, as per worldometres.info, there were 3,44,788 cases by late Tuesday evening and 9,926 deaths.

Tags: coronavirus treatment, coronavirus (covid-19), coronavirus test, coronavirus death toll, dexamethasone